Metalloproteinase 2 and 9 activity in the development of pancreatic cancer

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 84, Issue 8, 2012, Pages 377-382

  Durlik, Marek ^a,b   Gardian, Katarzyna ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b Ministry of the Internal Affairs in Warsaw   (Poland)

Author keywords

metalloproteinases; MMP; pancreatic cancer; pancreatic tumor

Indexed keywords

GELATINASE A; GELATINASE B;

ADENOCARCINOMA; ARTICLE; CELL DIFFERENTIATION; COMPARATIVE STUDY; DISEASE COURSE; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; PANCREAS; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PANCREAS; PANCREATIC NEOPLASMS;

EID: 84866848856     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-012-0064-6     Document Type: Article

References (14)

1. Raporty na podstawie danych Centrum Onkologii http://85.128.14.124/krn/
2. Singh P, Srinivasan R, Dev Wig J: Major Molecular Markers in Pancretic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis and Treatment, Pancreas 2011; 40: 644-52.
3. Neoptolemos JP, Urrutia RA, Abbruzzese J et al.: Pancreatic cancer. Springer 2010.
4. Egebald M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nature Rev Cancer 2002; 2:161-74.
5. Sullu Y, Demirag GG, Yildirim A et al.: Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast. Pathol Res Pract 2011; 207: 747-53.
6. Koyama H, Iwata H, Kuwabara Y et al.: Gelatinolytic activity of matrix metalloproteinase-2 and-9 in oesophageal carcinoma; a study using in situ zymography. Eur J Cancer 2000; 36: 2164-70.
7. Ellenrieder V, Alber B, Lacher U et al.: Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer 2000; 85:14-20.
8. Jones L, Humphreys M et al.: Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer: Increased Expression of Matrix Metalloproteinase-7 Predicts Poor Survival. Clin. Cancer Res 2004; 10: 2832-45.
9. Nakamura T, Kuwai T, Kim J et al.: Stromal Metalloproteinase-9 Is Essential to Angiogenesis and Progressive Growth of Orthotopic Human Pancreatic Cancer in Parabiont Nude Mice1. Neoplasia 2007; 9: 979-86.
10. Matsuyama Y, Takao S, Aikou T: Comparison of Matrix Metalloproteinase Expression Between Primary Tumors With or Without Liver Metastasis in Pancreatic and Colorectal Carcinomas. J Surg Oncol 2002; 80: 105-10.
11. Yokoyama M: Matrix Metalloproteinase-2 in Pancreatic Juice for Diagnosis of Pancreatic Cancer. Pancreas 2002; 24: 344-47.
12. Gialeli Ch, Theocharis A, Karamanos N: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting, 2011. FEBS Journal 2011; 278: 16-27.
13. H. Braat et al.: Pancreatic cancer: Promise for personalised medicine? Cancer Lett 2011; in press.
14. Collisson EA, Sadanandam A, Olson P et al.: Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nature Medicine 2011; 17: 500-04.